Terms ending in 2037
Every in-force patent on Actelion Pharmaceuticals Ltd's record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,011,444 | N-Substituted Indole Derivatives as PGE2 Receptor Modulators In force · High confidence | Idorsia Pharmaceuticals Ltd. | In force | High confidence | |
| US 10,653,846 | Dosing Appratus for Dispensing a Fluid Under Aseptic Conditions In force · High confidence | SHL Medical AG | In force | High confidence | |
| US 10,752,620 | Piperdine CXCR7 Receptor Modulators In force · High confidence | Idorsia Pharmaceuticals Ltd. | In force | High confidence | |
| US 10,730,896 | Crystalline Forms In force · High confidence | Viatris Asia Pacific Pte. Ltd. | In force | High confidence | |
| US 11,365,209 | Crystalline Forms In force · High confidence | Viatris Asia Pacific Pte. Ltd. | In force | High confidence | |
| US 12,227,532 | Crystalline Forms In force · High confidence | Viatris Asia Pacific Pte. Ltd. | In force | High confidence | |
| US 11,185,629 | Dosing Apparatus and Injection Device In force · High confidence | Idorsia Pharmaceuticals Ltd. | In force | High confidence | |
| US 11,174,247 | Combinations of a 4-Pyrimidinesulfamide Derivative with Active Ingredients for the Treatment of Endothelin Related Diseases In force · High confidence | Idorsia Pharmaceuticals Ltd. | In force | High confidence | |
| US 10,087,171 | Crystalline Forms of Cadazolid In force · High confidence | Actelion Pharmaceuticals Ltd. | In force | High confidence |
9 of 9 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Actelion Pharmaceuticals Ltd.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.